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BSA: bovine serum albumin 
cAMP: cyclic adenosine monophosphate 
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ABSTRACT 
 Freshly ejaculated mammalian spermatozoa have no ability to fertilize an egg. 
They gain this ability after entering the female reproductive tract. This phenomenon is 
called as sperm capacitation. An efflux of sterols from the sperm plasma membrane and 
the accompanied reconstitution of membrane lipid rafts are essential for capacitation. 
On the other hand, capacitated spermatozoa reversibly lose their fertilizing ability when 
they are treated with seminal plasma. This phenomenon is called decapacitation. In 
mouse, the major components of seminal plasma are seminal vesicle secretions (SVSs), 
consisting of seven major proteins (SVS1−SVS7). Previous reports have shown that 
SVS2 acts as a decapacitation factor, inhibiting sterol efflux from uterine spermatozoa 
via binding to ganglioside GM1. Since GM1 localizes on membrane lipid rafts, SVS2 
may affect the dynamics of lipid rafts, including the control of sterol dynamics. 
However, the precise regulatory mechanism of capacitation by SVS2 has not been 
elucidated. 
 In this thesis, I investigated the roles of SVS2, SVS3, and SVS4 in sperm 
capacitation and aimed to shed light on the regulatory mechanisms of capacitation by 
SVSs in general.  
 In Chapter I, I studied the inhibitory mechanism of capacitation by SVS2, 
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impeding the efflux of sterol from spermatozoa, retrieving cholesterol to spermatozoa in 
a cholesterol-dependent manner, and obstructing the reconstitution of lipid rafts 
accompanying capacitation. In the uterus, sterol levels of wild type spermatozoa were 
high, while sterol levels of SVS2-/- spermatozoa were decreased. These results indicate 
that SVS2 maintains the sterol level of spermatozoa to keep their incapacitated state in 
vivo. 
 In Chapter II, I studied the dynamics of SVS2 in vivo and the mechanism of in 
vivo capacitation. In mated female mice, SVS2 was found in the uterus and the 
uterotubal junction (UTJ), while no SVS2 was detected in the oviduct. Furthermore, 
GM1, which binds to SVS2, was detected along the uterine epithelium of estrus mice. 
These results indicate that SVS2 is excluded from the oviduct, where sperm capacitation 
occurs, and GM1 and SVS2 are released from spermatozoa at the UTJ. Since uterine 
fluid contains enough albumin to induce sperm capacitation, SVS2 actively inhibits 
capacitation of spermatozoa in the uterus. 
 3 章に関しては雑誌に投稿予定のため、非公開。  
 This study revealed that in vivo capacitation of mouse spermatozoa is 
dynamically regulated by cooperative effects of SVS2, other SVSs, and the milieu in the 
female reproductive tract. Controlling the sterol level in spermatozoa is important for 
  
Abstract                                                
 
6 
regulating sperm's fertilizing ability. Further studies on sterol level regulation by SVSs 
are expected to provide new insights into the mechanism of mammalian fertilization.   
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GENERAL INTRODUCTION 
 Effort to mimic in vivo fertilization in a test tube have been underway for a 
long time. The first observation of sperm penetrating an egg of an internal fertilizer was 
reported in the nematode Ascaris in 1851 (Nelson, 1851). In mammals, Schenk treated 
ovarian rabbit and guinea pig eggs with spermatozoa and observed their division 
(Schenk, 1878), before in vitro fertilization of many mammalian species, including 
humans, was described (Rock and Menkin, 1944). However, since in vitro fertilization 
required higher concentrations of spermatozoa than in vivo fertilization, events observed 
in vitro did not seem to reflect the in vivo situation. In addition, optimal conditions for 
mammalian fertilization were yet unknown. 
 In 1951, Austin and Chang reported that mammalian spermatozoa need to 
remain in the female reproductive tract for several hours before fertilization (Austin, 
1951; Chang, 1951). This result indicated that spermatozoa must undergo some changes 
in the female reproductive tract to acquire fertilizing ability, a phenomenon called 
"capacitation" (Austin, 1952). While capacitation had been assumed to occur only under 
in vivo conditions, Yanagimachi and Chang showed that it could be induced in vitro 
(Yanagimachi and Chang, 1963). That study significantly advanced our understanding 
of fertilization mechanisms in mammals and technically improved in vitro fertilization. 
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Consequently, efficient in vitro fertilization methods were established for animals and 
humans (Edwards et al., 1970). 
 In addition, mammalian in vivo fertilization has been studied intensively, 
leading to the following scheme for its process (Fig. 1). Spermatozoa are ejaculated into 
the vagina (man, sheep, cow, and rabbit) or the uterus (horse, pig, dog, and rat), migrate 
to the oviduct, and are reserved at the oviductal isthmus until ovulation. Sperm 
capacitation seems to occur in the isthmic reservoir (Martinez, 2007). Capacitated 
spermatozoa undergo hyperactivation, gaining activated motility, accompanied by 
asymmetrical flagellar beats of large amplitude (Katz et al., 1989), and are released 
from the reservoir (Demott and Suarez, 1992). Then the acrosome reaction is induced, 
changing the sperm plasma membrane in preparation for fusion with the egg. Finally 
spermatozoa penetrate the zona pellucida and fuse with the egg's plasma membrane. 
 During capacitation, sperm undergo various morphological and functional 
changes. The plasma membrane becomes hyperpolarized (Zeng et al., 1995), and the 
intracellular Ca2+ concentration increases (Baidi et al., 1991; Florman et al., 1998). 
Adenylyl cyclase and cAMP-dependent protein kinase A are activated (Visconti et al., 
1995b), resulting in tyrosine phosphorylation of sperm proteins (Visconti et al., 1995a). 
Furthermore, properties of the sperm plasma membrane change drastically. The plasma 
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membrane of ejaculated spermatozoa is abundant in certain sterols, particularly 
cholesterol (Tesařík and Fléchon, 1986; Parks et al., 1987). Spermatozoa obtain sterols 
from principal cells during maturation in the epididymis (Keber et al., 2013). This keeps 
the fluidity and order of the membrane (Parks et al., 1987; Almeida et al., 1992), while, 
in contrast, sterols are decreased during capacitation (Davis, 1981), resulting in 
reconstitution and redistribution of the sperm plasma membrane (Shadan et al., 2004; 
Jones et al., 2010). Thus, sterol efflux is associated with the signal transduction pathway 
for sperm capacitation (Visconti et al., 1999a).  
 Sperm capacitation can be induced in vitro by a medium containing appropriate 
components (Byrd et al., 1979; Miyamoto and Chang, 1973) such as bovine serum 
albumin (BSA) (Brackett et al., 1972; Davis, 1976) and methyl-β-cyclodextrin (MβCD) 
(Choi and Toyoda, 1998). MβCD removes sterols from the plasma membrane (Choi and 
Toyoda, 1998), and BSA seems to act accordingly (Davis et al., 1979). Since sperm 
capacitation seems to occur in the oviductal fluid, where albumin concentrations are 
high (Miyamoto and Chang, 1973), albumin may act as an in vivo capacitation-inducing 
factor by liberating sterols from spermatozoa. 
 While sperm capacitation is essential for mammalian fertilization, the in vitro 
capacitated spermatozoa reversibly lose their fertilizing ability when treated with 
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seminal plasma (Chang, 1957). This phenomenon is called "decapacitation" and appears 
to be conserved among several species (Bedford and Chang, 1962). Certain molecules 
such as polysaccharide (Dukelow et al., 1966), glycoprotein (Rayes et al., 1975), and 
some membrane vesicle (Davis, 1974) are assumed to function as decapacitation factors. 
Considering the importance of sperm capacitation for accomplishing fertilization, the 
existence of decapacitation factors is a mystery. However, these factors may play an 
important role by inhibiting sperm capacitation.  
 The functions of spermatozoa are regulated by many secretions from male 
reproductive accessory glands; these secretions are accumulated in semen. In mice, the 
seminal vesicle is the predominant reproductive accessory gland, secreting seven major 
proteins called seminal vesicle secretions (SVSs) (Fawell et al., 1987). SVSs constitute 
a major component of seminal plasma and have many functions in copulation and 
fertilization; SVS1−SVS3 are cross-linked by transglutaminase and form the copulatory 
plug (Lin et al., 2002); SVS4 shows immunoregulatory activity (Romano-Carratelli et 
al., 1995); SVS5 and SVS6 may act as serine proteinase inhibitors (Clauss et al., 2005); 
and SVS7 enhances sperm motility (Luo et al., 2001). 
 SVS2 acts as a decapacitation factor (Kawano and Yoshida, 2007). While 
SVS2 is a major component of the copulatory plug, it partly enters the uterus, inhibits 
  
General Introduction                                                   
 
11 
sperm capacitation and also cancels acquired sperm fertility in vitro (decapacitation). In 
the uterus, SVS2 binds to spermatozoa via ganglioside GM1 on the sperm plasma 
membrane, whereas the spermatozoa entered the oviduct have neither SVS2 nor GM1 
(Kawano et al., 2008). Recently, Kawano et al. generated SVS2-/- mice and reported that 
after mating, SVS2-/- spermatozoa were killed in the uterus and cannot enter the oviduct, 
resulting in male infertility (Kawano et al., 2014). Therefore, the in vivo suppression of 
capacitation by SVS2 seems to be essential for sperm viability in the uterus, but its 
regulatory mechanism is not clear. Moreover, it is not known whether other SVSs 
participate in the regulation of sperm capacitation. 
 In this study, I aimed to elucidate the roles of SVSs in the regulation of sperm 
capacitation. In Chapter I, I explicated the inhibitory mechanism of sperm capacitation 
by SVS2. In Chapter II, I analyzed the dynamics of SVS2 in the female reproductive 
tract and studied the in vivo capacitation mechanism. In Chapter III, I evaluated roles of 
SVS3 and SVS4 in capacitation. In terms of the participation of SVSs, I attempted to 
explain the "raison d'etre" of a decapacitation factor and the capacitation-regulatory 
mechanism in vivo.  
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Figure 1. Schematic diagram depicting the journey of spermatozoa and 
fertilization in mammals. 
(1) Spermatozoa are ejaculated into the vagina or the uterus. (2) Spermatozoa migrate to 
the oviduct and are reserved at the oviductal isthmus until ovulation. (3) Sperm 
capacitation occurs in the isthmic reservoir. (4) Capacitated spermatozoa undergo 
hyperactivation and are released from the reservoir. (5) Spermatozoa undergo acrosome 
reaction. (6) Spermatozoa penetrate the zona pellucida and fuse with the plasma 
membrane of the egg. 
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ABSTRACT 
 The seminal vesicle secretion 2 (SVS2) functions as a decapacitation factor. 
SVS2 binds to ganglioside GM1 on the sperm plasma membrane and inhibits sperm 
capacitation. Furthermore, SVS2-/- male mice are infertile, whose spermatozoa are killed 
by some spermicidal activity in the uterus. Although its precise mechanism is still 
obscure, SVS2 seems to be involved in the dynamics of lipid rafts. Here, I examined the 
role of SVS2 on the regulatory mechanism of sperm capacitation, especially focused on 
the effect of SVS2 on sterol level in the sperm plasma membrane and 
capacitation-accompanied reconstitution of membrane lipid rafts. SVS2 prevented the 
sperm capacitation induced by methyl-β-cyclodextrin that liberates sterols from the 
sperm plasma membrane in vitro. SVS2 prevented cholesterol efflux from the sperm 
plasma membrane and incorporated liberated cholesterol in the sperm plasma membrane. 
SVS2 also inhibited capacitation-accompanied diffusion of GM1. SVS2-/- mice 
spermatozoa entered the uterine cavity of wild-type partners showed decreased sterol 
levels, while sterol level of wild type spermatozoa were maintained. These results 
suggest that SVS2 maintains sterol level of the sperm plasma membrane to keep their 
incapacitated state in vivo. SVS2 seems to protect sterols in the sperm plasma 
membrane from flowing out in the uterus.  
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INTRODUCTION 
 Mammalian spermatozoa need to experience a specific change called sperm 
capacitation in the female reproductive tract to acquire the fertilizing ability (Austin, 
1951; Chang, 1951). One of important steps in capacitation is efflux of sterols from the 
sperm plasma membrane (Go and Wolf, 1985). Although main sterols in spermatozoa 
are cholesterol and desmosterol (Legault et al., 1979), cholesterol seems to be a main 
actor in sperm capacitation. Capacitation is associated with changes in the fluidity of the 
sperm plasma membrane accompanied by sterol efflux (Shadan et al., 2004). This yields 
changes in intracellular ion concentration, metabolism, tyrosine phosphorylation of 
sperm proteins, and sperm motility (Bailey, 2010; Visconti et al., 2011), which are all 
steps required to achieve sperm capacitation. 
 In general, the plasma membrane forms cholesterol- and sphingolipid-enriched 
microdomains known as lipid rafts, which functions in signaling, membrane trafficking, 
and polarization (Rajendran and Simons, 2005). Cholesterol is a major component of 
lipid rafts and plays significant roles in stability and function of the plasma membrane 
(Simons and Toomre, 2000; Fielding and Fielding, 2003). The lipid and sterol 
composition of the sperm plasma membrane changes drastically as a result of two main 
events. First, as spermatozoa undergo epididymal maturation, they obtain sterols from 
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their environment (Suzuki, 1988; Keber et al., 2013). Second, in the female 
reproductive tract, sperm capacitation seems to be induced by a reduction of sterols in 
the plasma membrane (Davis, 1981). Cholesterol efflux from spermatozoa destabilizes 
lipid rafts (Shadan et al., 2004), resulting in capacitation (Cross, 1998). This cholesterol 
efflux is associated with activation of the signal transduction pathway necessary for 
sperm capacitation (Visconti et al., 1999a), and redistributes the molecules required for 
fertilization (Jones et al., 2010).  
 Albumin (Brackett et al., 1972; Davis, 1976) and methyl-β-cyclodextrin 
(MβCD; Choi and Toyoda, 1998) can liberate sterols from the sperm plasma membrane, 
which induces sperm capacitation in vitro. Although the importance of sterol efflux in 
capacitation has been recognized, the specific mechanism underlying in vivo 
capacitation, including the regulation of sterols in the sperm plasma membrane, is not 
well understood.  
 The seminal plasma protein, seminal vesicle secretion 2 (SVS2) is secreted 
from the seminal vesicle and is ejaculated with spermatozoa into the uterus. SVS2 
functions as a decapacitation factor: it prevents spermatozoa from acquiring the 
fertilizing ability (Kawano and Yoshida, 2007). Recently it was shown that spermatozoa 
of SVS2-/- males are killed by some spermicidal activity in the uterus, resulting in 
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infertility (Kawano et al., 2014). SVS2 binds to the ganglioside GM1 in the sperm 
plasma membrane (Kawano et al., 2008) and was found attached to the surface of 
spermatozoa in the uterus (Kawano and Yoshida, 2007; Kawano et al., 2014). However, 
after entering the oviduct, spermatozoa are attached to neither SVS2 nor GM1 (Kawano 
and Yoshida, 2007; Kawano et al., 2008). Since GM1 is a marker of lipid rafts (Parton, 
1994) and cholesterol efflux accompanied by sperm capacitation reconstitutes lipid rafts 
(Shadan et al., 2004; Jones et al., 2010), it is possible that SVS2 is involved in the 
dynamics of cholesterol and lipid rafts. 
 In this chapter, I tried to elucidate the role of SVS2 and sterols on sperm 
capacitation. I focused on the effect of SVS2 on the dynamics of lipid rafts and sterol 
levels in the sperm plasma membrane. 
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MATERIALS AND METHODS 
Animals 
 All mice were purchased from Charles River Laboratories Japan (Kanagawa, 
Japan). Mice were housed in cages under a 12 h: 12 h light-dark cycle. All animal 
experiments were carried out according to the University of Tokyo Guidelines on 
Animal Care. 
 
Preparation of Recombinant SVS2 Protein 
 Because it was shown that the GST-tagged recombinant SVS2 protein has the 
same effect as the native SVS2 protein (Kawano and Yoshida, 2007), I used 
recombinant SVS2 protein. To increase the solubility of recombinant SVS2, I 
substituted the thioredoxin (Trx)-tag for a GST-tag. cDNA encoding SVS2 (NCBI 
accession No.NM_017390) was prepared by reverse transcription-polymerase chain 
reaction (RT-PCR) using RNA isolated from the mouse seminal vesicle (C57BL/6J). 
The cDNA was subcloned into the pET-32 vector (Takara Bio Inc.; Shiga, Japan). The 
Trx fusion protein was expressed in Escherichia Coli BL21-pLysS cells (Novagen; 
Madison, WI, USA) by induction with 1 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). Recombinant SVS2 protein was recovered using Ni-NTA agarose (Qiagen; 
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Hilden, Germany) under denaturing conditions according to the manufacturer’s 
instructions. After removing urea using a PD-10 column (GE Healthcare; Piscataway, 
NJ, USA), the protein was lyophilized and stored at −20°C until use. Immediately 
before the experiment, recombinant SVS2 was dissolved in human tubal fluid (HTF) 
medium without BSA (Nippon Medical & Chemical Instruments Co.; Osaka, Japan).  
 The purity of recombinant SVS2 protein was evaluated by western blotting 
with anti-SVS2 antibody produced by previous report (Kawano and Yoshida, 2007). 
Protein was separated by Laemmli SDS-PAGE using a 10% (w/v) polyacrylamide gel, 
and transferred onto a polyvinylidene fluoride membrane (Millipore; Billerica, MA, 
USA). The membrane was blocked with 5% (w/v) skim milk (Nacalai Tesque; Kyoto, 
Japan) in phosphate-buffered saline (PBS) with 0.1% (w/v) Tween-20 (Sigma-Aldrich; 
St. Louis, MO, USA) (PBS-T) for 30 min at room temperature. The membrane was 
treated with 20 µg/mL of anti-SVS2 antibody in PBS-T containing 5% (w/v) skim milk 
at 4°C for 12 h. After washing with PBS-T, the membrane was treated with horseradish 
peroxidase-conjugated anti-rabbit IgG antibody (Bethyl Laboratories; Montgomery, TX, 
USA) at a dilution of 1: 20,000 in PBS-T containing 5% (w/v) skim milk for 1 h at 
room temperature, and washed three times with PBS-T. Reacted proteins were detected 
with ECL Prime Western Blotting Detection Reagent (GE Healthcare). Proteins were 
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also visualized by staining with Coomassie Brilliant Blue R250.  
 
Preparation of Epididymal Spermatozoa and Incubation for Capacitation 
 To evaluate the effect of SVS2 on sperm capacitation in vitro, spermatozoa 
were isolated from the cauda epididymis of sexually mature male CD-1 mice (9−15 
weeks old), and were suspended in HTF medium at 37°C in a 5% CO2 atmosphere. 
 I used methyl-β-cyclodextrin (MβCD; Sigma-Aldrich) and bovine serum 
albumin (BSA, A-4503; Sigma-Aldrich) to induce sperm capacitation. SVS2 was used 
at a concentration of 20 µM, which is similar to the physiological concentration in the 
uterus (Kawano and Yoshida, 2007). Schematic image of sperm incubating conditions 
was shown in Fig. 2. To wash the spermatozoa, HTF medium (37°C) was added to 
spermatozoa, which were gently suspended. After centrifugation at 600 × g for 3 min, 
the supernatant was removed. After repeating this procedure twice, the medium was 
replaced. Next, SVS2, BSA, MβCD, and cholesterol were added to the replaced 
medium. Cholesterol conditions were as follows: 50 mM cholesterol (Sigma-Aldrich) 
dissolved in 100% ethanol was added to obtain a final concentration of 500 µM.  
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Observation of Sterols by Filipin Staining 
 To visualize sterols, the filipin complex (Sigma-Aldrich) was used, which binds 
to sterols (Schroeder et al., 1971; Kessel et al., 1985). Spermatozoa were fixed with 
0.004% (w/v) paraformaldehyde (PFA) for 10 min and washed twice with 
HEPES-buffered saline (HBS; 25 mM HEPES, 140 mM NaCl, 5 mM KCl, 0.75 mM 
Na2HPO4, 6 mM glucose, pH 7.1). Filipin solution (4% (w/v) in dimethyl sulfoxide) 
was added to the fixed spermatozoa at a final concentration of 0.2%, and the solution 
was incubated for 30 min. After washing with HBS, fluorescence was observed using a 
fluorescent microscope (Leica DMRBE; Solms, Germany) and images were acquired 
using a CCD camera (MicroPublisher 5.0; QImaging; BC, Canada). The fluorescence 
intensity of the sperm head was quantified using ImageJ software (NIH; Bethesda, MD, 
USA), and the normalized intensity of epididymal spermatozoa was set to 100. For each 
batch, the fluorescence intensities of 100 spermatozoa were quantified. 
 
Visualization of Cholesterol Dynamics in the Sperm Plasma Membrane 
 To verify that SVS2 affects sterol dynamics, intercalation of fluorescent 
cholesterol into the sperm plasma membrane was studied. Spermatozoa were incubated 
in HTF medium containing 500 µM MβCD for 45 min. After washing as described 
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above, spermatozoa were incubated in replaced HTF medium containing 20 µM SVS2 
and 500 µM BODIPY-cholesterol (TopFluor-Cholesterol; Avanti Polar Lipids; 
Alabaster, AL, USA) and incubated for 45 min. Spermatozoa were then stained with 
Hoechst 33342 (Sigma-Aldrich) at a final concentration of 5 µg/mL. After incubating 
for 5 min, fluorescence was visualized using a fluorescent microscope (Leica DMRBE; 
Solms, Germany) and images were acquired using a CCD camera (MicroPublisher 5.0; 
QImaging; BC, Canada). 
 
Quantitation of Sperm Cholesterol 
 Lipid extraction was performed according to modified Bligh & Dyer as 
described by Jakop et al. (Jakop et al., 2009). Briefly, spermatozoa incubated in various 
conditions were centrifuged (1,000 × g, 5 min) after washed with HBS. 100 µL of sperm 
suspensions were mixed with 400 µL of chloroform/methanol (1: 2, v/v) and shaken for 
30 min. The sperm were added with 130 µL chloroform and shaken for 0.5 min. 130 µL 
of 40 mM acetic acids was added and samples were shaken. After centrifugation (1,000 
× g, 20 min, 4°C), samples were divided into the chloroform phase and the aqueous 
phase. The aqueous phase was treated with chloroform and acetic acids and centrifuged 
as described above. After repeating reextraction two times, whole chloroform phases 
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were combined and dried under reduced pressure. 
 Extracted lipids were suspended with 2-propanol containing 10% (v/v) Triton 
X-100. Enzymatic quantitation of cholesterol was carried out with Amplex red 
cholesterol assay kit (Molecular probes, Eugene, OR, USA). Fluorescence intensity was 
measured by a multilabel reader 2030 ARVO X4 (Perkin Elmer, Waltham, MA, USA).  
 
Sperm Capacitation Assay 
 Sperm capacitation was evaluated based on acrosomal responsiveness to 
progesterone and ionomycin. Spermatozoa were treated with 100 µM progesterone 
(Wako; Kyoto, Japan) for 15 min at 37°C or with 15 µM ionomycin (Sigma-Aldrich) for 
10 min at room temperature. Treated spermatozoa were spread onto a glass slide. 
Spermatozoa were fixed by 100% methanol for 10 min and stained with 100 µg/mL 
fluorescein isothiocyanate (FITC)-conjugated peanut lectin (Sigma-Aldrich) for 15 min 
at 37°C. Spermatozoa were washed with HBS, and FITC fluorescence was observed 
using a fluorescent microscope (Leica DMRBE; Solms, Germany) and images were 
acquired using a CCD camera (MicroPublisher 5.0; QImaging; Surrey, BC, Canada). 
Spermatozoa with no FITC fluorescence at the acrosome region were regarded as 
acrosome-reacted spermatozoa. Three fields were obtained for each batch, and 100 
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spermatozoa per field were evaluated. 
 
Localization of GM1 in the Spermatozoa 
 The ganglioside GM1 (Galβ1 > 3GalNAcβ > 4(NeuAcα2>3)Galβ1 > 4Glcβ1 > 
1'Cer) was visualized using FITC-conjugated cholera toxin B subunit (FITC-CTB) 
(Sigma-Aldrich) which is known to bind to GM1 specifically (van Heyningen, 1974). 
Spermatozoa were fixed with 0.004% (w/v) PFA for 10 min and washed three times 
with HBS. Fixed spermatozoa were added FITC-CTB at a final concentration of 0.5 
mg/mL in HBS for 10 min. After washing with HBS, fluorescence was observed as 
described above. Localization of the GM1 signal was classified into four patterns based 
on previously described criteria (Selvaraj et al., 2006), and 100 signals were evaluated 
for each batch. 
 
Evaluation of the Sterol Level of Spermatozoa in vivo 
 To evaluate the effect of SVS2 on the sperm sterol content in the female 
reproductive tract, I measured the sterol level of spermatozoa in the uterus and the 
oviduct. A 10−55-week-old male mouse (SVS2+/+ or SVS2-/-) was mated with a 
9−12-week-old C57BL/6J female mouse. SVS2-/- mice were generated as described by 
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Kawano et al. (Kawano et al., 2014). Briefly, targeting vector designed to remove SVS2 
exons were electroporated into 129/Sv strain-derived ES cells. Recombinant ES lines 
were microinjected into C57BL/6J strain-derived blastocytes and the male chimeric 
mice were obtained. They were crossed with C57BL/6J female mice to produce 
heterozygote offspring. Then male and female heterozygotes were intercrossed and 
backcrossed to the C57BL/6N background. Females were sacrificed at 1.5 h post-coitus, 
and spermatozoa were obtained from the uterus and the oviduct by flushing with HBS. 
Obtained spermatozoa were fixed with 0.004% PFA for 10 min, stained with filipin, and 
the fluorescence intensity was quantified as described above.  
 
Evaluation of Sperm Viability 
 To evaluate the viability of spermatozoa, propidium iodide (PI; Dojindo; 
Kumamoto, Japan) was added to sperm suspension with various treatments at a final 
concentration of 5 µg/mL, and incubated for 5 min at 37°C. After incubation, PI 
fluorescence was observed under a heating plate at 37°C using a fluorescence 
microscope (Leica DMRBE; Solms, Germany). Spermatozoa with no fluorescence were 
regarded as live. 100 spermatozoa were evaluated for each experiment. 
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Statistical Analysis 
 All experiments were repeated at least three times with different individuals. 
Data are expressed as mean ± SD. Statistical significance was calculated using the 
Student's t-test; P < 0.01 was considered statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter I                                                 
 
27 
RESULTS 
Sterol Level of SVS2-/- Mice Spermatozoa Deposited into the Female Reproductive 
Tract 
 At first, I visualized sterol level of mouse spermatozoa in the female 
reproductive tract with the sterol-staining dye filipin and confirmed whether sterol level 
of spermatozoa and fertilizing ability are correlated in vivo. Typical images of filipin 
staining were shown in Fig. 3. Intensity of filipin fluorescence of wild-type male 
spermatozoa entered the uterus after mating increased by 149 ± 40% compared to 
non-treated epididymal spermatozoa (n = 6) (Fig. 4). On the other hand, the 
fluorescence intensity of the spermatozoa in the oviduct was significantly reduced (35 ± 
17% of that in the uterus) (n = 3, P < 0.01) (Fig. 4). This shows that sterol level of the 
mouse spermatozoa is really decreased when they enter the oviduct. On the other hand, 
the sperm sterol level in the uterus of females mated with SVS2-/- males was reduced to 
the level of wild spermatozoa in the oviduct (34 ± 7% of that of ejaculated wild-type 
spermatozoa in the uterus) (n = 8, P < 0.01) (Fig. 4). These results indicate that SVS2 
preserves sterols on the sperm membrane in the female reproductive tract until entrance 
into the oviduct.  
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Effect of MβCD on Sperm Capacitation 
 MβCD is a potent liberator of sterols, and induces capacitation of mouse 
spermatozoa (Choi and Toyoda, 1998). I confirmed the effect of MβCD on sperm 
capacitation. Capacitation was evaluated by acrosomal responsiveness to progesterone 
and ionomycin (induced-AR rate) as described in Materials and Methods. Spermatozoa 
incubated with MβCD showed increased induced-AR rate and 500 µM MβCD induced 
the same level of the induced-AR rate as BSA (Fig. 5). 
 
Effect of SVS2 on Sperm Capacitation Induced by MβCD 
 In order to examine the effect of SVS2 on sperm capacitation and sterol efflux, 
I examined the effect of SVS2 on the MβCD-treated spermatozoa. Expression and 
purification of recombinant SVS2 protein were checked with CBBR staining and 
western blotting with anti-SVS2 antibody (Fig. 6). Although recombinant SVS2 was 
expressed with thioredoxin (Trx)-tag, the tag itself has no effect on the induced-AR rate 
(Fig. 7).  
 The spermatozoa incubated with SVS2 and MβCD suppressed the induced-AR 
rate, which showed no significant differences from that of control spermatozoa (Fig. 8). 
The spermatozoa incubated with SVS2 prior to incubating with MβCD also suppressed 
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the induced-AR rate (Fig. 8). Furthermore, SVS2 cancelled sperm capacitation induced 
by MβCD: SVS2 showed decapacitation effect on MβCD-treated spermatozoa. When 
SVS2 was added to the MβCD-treated spermatozoa, which should be capacitated, the 
induced-AR rate decreased significantly (MβCD → SVS2 in Fig. 9). When SVS2 was 
added to BSA-treated spermatozoa, the induced-AR rate of spermatozoa did not show 
significant difference (Fig. 9). This may be because the incubation time of 45 min is not 
enough for capacitation induced by BSA.  
 Interestingly, the decapacitation effect of SVS2 was not observed when sperm 
incubation medium was washed out following MβCD-treatment. When MβCD-treated 
spermatozoa were washed with new HTF medium after MβCD-treatment, addition of 
SVS2 did not decrease the induced-AR rate (MβCD → wash → SVS2 in Fig. 10). 
However, the decapacitation effect of SVS2 on the washed MβCD-treated spermatozoa 
was rescued by addition of cholesterol (MβCD → wash → SVS2 + Ch in Fig. 10), 
though cholesterol itself and sterol liberators, MβCD and BSA had no effect on the 
washed MβCD-treated spermatozoa (Fig. 10). In addition, 1% ethanol, a vehicle of 
cholesterol, had no effect on sperm viability (Fig. 11) and capacitation (Fig. 12). These 
results indicate that the decapacitation effect of SVS2 requires cholesterol in the 
medium surrounding the spermatozoa.   
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Effect of SVS2 on Sterol Level in the Sperm Plasma Membrane 
 As describe above, sterol level on the SVS2-/- spermatozoa was significantly 
reduced in the uterus. Furthermore the decapacitation effect of SVS2 seems to closely 
relate to the existence of surrounding cholesterol. Thus, I examined the effect of SVS2 
on sterol levels in the sperm plasma membrane in vitro.  
 Although recombinant SVS2 protein was expressed with Trx-tag, the tag itself 
has no effect on sterol level in the spermatozoa (Fig. 13). Fluorescence intensity of 
filipin in the sperm heads treated with 500 µM MβCD for 45 min decreased to 
approximately 55% of that of non-treated sperm heads (Fig. 14). On the other hand, 
SVS2 inhibited decrease in sterol content of the spermatozoa; the fluorescence intensity 
on sperm heads treated with SVS2 and MβCD showed no significant differences from 
that on non-treated sperm heads (Fig. 14). When spermatozoa were incubated with 
SVS2 prior to MβCD-treatment, the sterol level on the sperm head was maintained to 
show the same level as that of spermatozoa incubated HTF medium only (SVS2 → 
MβCD in Fig. 14). Furthermore, when SVS2 was added to the MβCD-treated 
spermatozoa, on which the membrane sterol level was low, sterol levels on the sperm 
heads recovered to that of incapacitated spermatozoa (MβCD → SVS2 in Fig. 14). 
These changes in sperm sterol levels were confirmed by enzymatic quantitating analysis. 
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Cholesterol content in the control spermatozoa was 142.3 ± 39.5 ng/106 sperm cells. 
MβCD-treatment decreased the sperm cholesterol by approximately 35%, whereas 
SVS2-treatment kept the sperm cholesterol to control level (MβCD + SVS2 and MβCD 
→ SVS2 in Fig. 15). Thus, SVS2 appears to mediate sperm capacitation by controlling 
sterol levels in the plasma membrane.    
 When the MβCD-treated spermatozoa were washed with new HTF medium, a 
recovery effect of SVS2 on the sterol level in the spermatozoa was not observed by the 
filipin staining and the enzymatic quantitating assay (MβCD → wash → SVS2 in Fig. 
14 and 15). However, addition of extrinsic cholesterol to the medium containing SVS2 
rescued the sterol level in the sperm head (MβCD → wash → SVS2 + Ch in Fig. 14 and 
15). Accordingly, SVS2 seems to prevent sterol efflux from the plasma membrane, 
thereby retrieving liberated sterols to the membrane and maintaining the spermatozoa in 
an incapacitated state.   
 
Visualization of Cholesterol Dynamics in the Sperm Plasma Membrane 
 My results suggest that SVS2 does not only inhibit sterol efflux, but also 
incorporates external sterol into the sperm plasma membrane. To verify the effect of 
SVS2, I observed the dynamics of extrinsic BODIPY-cholesterol. When only 
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BODIPY-cholesterol was added to the washed MβCD-treated spermatozoa, minimal 
BODIPY fluorescence was observed (Fig. 16A). By contrast, when washed 
MβCD-treated spermatozoa were incubated with BODIPY-cholesterol and SVS2, 
BODIPY fluorescence was observed on many spermatozoa. BODIPY-cholesterol was 
incorporated into 69 ± 20% of spermatozoa (Fig. 16B). Furthermore, SVS2 slightly 
facilitated incorporation of BODIPY-cholesterol into the spermatozoa without 
MβCD-treatment (Fig. 16). Thus, SVS2 mediates incorporation of free cholesterol in the 
medium surrounding spermatozoa into the sperm plasma membrane.  
 
Effect of SVS2 on Distribution of GM1 in Spermatozoa 
 Sterol efflux from spermatozoa changes fluidity of plasma membrane and 
reorganizes the lipid rafts to induce sperm capacitation (Shadan et al., 2004; Jones et al., 
2010). Thus, I evaluated the effect of SVS2 on the distribution of ganglioside GM1, 
which is a well-known marker of lipid rafts. GM1 was visualized using 
FITC-conjugated cholera toxin B subunit (CTB), and the GM1 staining pattern was 
classified into four types based on criteria described by Selvaraj et al. (Selvaraj et al., 
2006) (Fig. 17A). GM1 was primarily observed in the postacrosomal region, and 
occasionally on the entire sperm head (pattern PAPM or pattern APM/PAPM), when 
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spermatozoa were incubated in medium only; non-capacitated spermatozoa (Fig. 17B 
and Table 1). When spermatozoa were capacitated using MβCD, GM1 diffused through 
the entire head, appearing as pattern D (Fig. 17B and Table 1). When spermatozoa were 
co-incubated with SVS2 and MβCD, the pattern APM/PAPM was observed in a large 
proportion of spermatozoa and pattern D was seen in a low percentage of spermatozoa, 
which was similar to the patterns observed in non-capacitated spermatozoa (Fig. 17B 
and Table 1). In the spermatozoa pre-incubated with SVS2 prior to incubating with 
MβCD, distribution of GM1 was also similar to the non-capacitated spermatozoa (Fig. 
17B and Table 1). Thus, SVS2 arrests the reconstitution of lipid rafts organization by 
preventing sterol efflux. 
 Furthermore, when the MβCD-treated spermatozoa were decapacitated using 
SVS2, GM1 was primarily distributed in the APM/PAPM pattern, similarly to the 
non-capacitated spermatozoa, although GM1 was dispersed over the entire sperm head 
(pattern D) before SVS2 addition (MβCD → SVS2 in Fig. 17B and Table 1). This 
suggests that SVS2 restores lipid rafts organization by retaining membrane sterols. On 
the other hand, wash of the MβCD-treated spermatozoa prevented the effects of SVS2 
on the GM1 staining pattern; pattern D was observed in the highest percentage for the 
spermatozoa, which was similar to the capacitated spermatozoa (MβCD → wash → 
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SVS2 in Fig. 17B and Table 1). Addition of extrinsic cholesterol to the washed 
MβCD-treated spermatozoa rescued the effects of SVS2; the ratio of spermatozoa 
showing pattern APM/PAPM increased, while the ratio of spermatozoa showing pattern 
D decreased (MβCD → wash → SVS2 + Ch in Fig. 17B and Table 1). Cholesterol itself 
and cholesterol with MβCD showed no effect on GM1 patterns of the washed 
MβCD-treated spermatozoa. These results suggest that the effect of SVS2 on the 
reconstitution of lipid rafts requires free cholesterol in the medium surrounding 
spermatozoa. SVS2 appears to restrict sterol dynamics by altering sperm plasma 
membrane fluidity.  
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DISCUSSION 
 In this chapter, I demonstrated that SVS2 maintains sterols in the sperm plasma 
membrane to arrest sperm capacitation. Interestingly, SVS2 retrieved exogenous 
cholesterol into the spermatozoa and reset the distribution of lipid rafts, suggesting 
cholesterol is essential for decapacitation. These results are consistent with the results of 
previous studies demonstrating that cholesterol is required to prevent sperm capacitation 
(Davis, 1978; Zarintash and Cross, 1996).  
  The cholesterol concentration on the sperm plasma membrane increases during 
epididymal transit (Suzuki, 1988; Keber et al., 2013). Furthermore, seminal plasma 
contains a high concentration of cholesterol (Suarez, 2008), and spermatozoa appear to 
obtain cholesterol even after ejaculation. Thus, spermatozoa ejaculated into the uterus 
contain a high concentration of sterol and lose their sterol during capacitation. The 
cholesterol efflux triggers Ca2+ influx and acrosome exocytosis via GM1 dynamics 
(Cohen et al., 2014). Accordingly, SVS2 may function to maintain the sterol level of 
spermatozoa and suppress capacitation of spermatozoa in the uterus. The precise 
mechanism SVS2 maintains sterol in the sperm plasma membrane remains unknown. 
Seven consensus regions that recognize and interact with cholesterol are present in the 
SVS2 amino acid sequence (Fig. 18). Moreover, previous study showed that SVS2 
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directly interacts with GM1 (Kawano et al., 2008). Thus, SVS2 may bind both GM1 
and cholesterol. GM1 may act as a membrane scaffold for SVS2, and SVS2 can inhibit 
sterol efflux and then retrieve liberated sterol into the sperm plasma membrane via 
binding to GM1.  
 It is interesting how sterols in the sperm plasma membrane are pulled out and 
how exogenous sterols are incorporated into the sperm plasma membrane. The 
mechanism which cyclodextrin (CD) removes cholesterol from the plasma membrane 
has been presumed by molecular dynamics simulation (López et al., 2011). CD has a 
rigid conical molecular structure and a cavity that can include various molecules. At 
first, four CD dimers bind to the membrane surface. Cholesterol is embedded in the 
cavity of CD and they are bound by hydrogen bond. The complex of CD and cholesterol 
desorbs from the membrane surface by a large free energy barrier. Finally, liberated 
cholesterol molecule is transferred to lipid vesicle or lipoprotein by a simple diffusion 
mechanism. Albumin is a potent candidate of the in vivo sterol liberator. Albumin has 
hydrophobic domains interacting with various hydrophobic ligands (Spector, 1986; He 
and Carter, 1992) and this structural feature also functions in liberating sterol from the 
plasma membrane.  
 Considering previous reports, SVS2 may regulate sterols in the sperm plasma 
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membrane as follows. Sterols in the sperm plasma membrane are removed by sterol 
liberators such as BSA and MβCD. After receiving sterols from sterol liberators, SVS2 
binds to spermatozoa via GM1 and incorporates sterols into the sperm plasma 
membrane. Practically, since SVS2 appears to protect sperm sterols, high level of sterol 
is maintained in the sperm plasma membrane.     
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Figure 2. Schematic image of sperm incubating conditions. 
MβCD: 0.5 mM, SVS2: 20 µM, Ch: 0.5 mM, BSA: 5 mg/mL, wash: spermatozoa are 
suspended with new medium and centrifuged for two times. 
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Figure 3. Spermatozoa stained with filipin. 
Typical filipin staining of the non-treated spermatozoa with sterol intact (upper panel), 
and the capacitated spermatozoa after the efflux of sterol (lower panel) are shown. Scale 
bar: 5 µm.  
 
 
 
 
  
Chapter I                                                 
 
40 
 
 
 
 
 
 
 
Figure 4. Sterol levels of SVS2-/- and wild type spermatozoa deposited into the 
female reproductive tract. 
Sterol levels in the plasma membrane of spermatozoa of SVS2-/- (white bar) and wild 
type (WT) (gray bars) male mice collected from the uterus and the oviduct of wild-type 
female mice. The graph shows the relative filipin fluorescence intensity values 
compared to epididymal spermatozoa. Data are shown as mean ± SD. n = 8 (SVS2-/- 
spermatozoa in the uterus); n = 6 (WT spermatozoa in the uterus); and n = 3 (WT 
spermatozoa in the oviduct). No spermatozoa were found in the oviduct of the female 
mated with SVS2-/- male. The fluorescence intensity of the SVS2-/- spermatozoa showed 
a significant difference compared to that of the WT spermatozoa in the uterus (asterisks; 
P < 0.01, Student’s t-test). 
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Figure 5. Effect of MβCD on sperm capacitation. 
The rate of the acrosome reaction induced by progesterone (gray bars) or ionomycin 
(white bars) was evaluated. Data are shown as mean ± SD. Asterisks indicate significant 
differences compared with the spermatozoa incubated in HTF medium only (P < 0.01, 
Student’s t-test) (n = 3). 
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Figure 6. Western blotting of recombinant SVS2 protein. 
Purified Trx-tagged SVS2 and Trx recombinant proteins were electrophoresed by 
SDS-PAGE and western blotting with anti-SVS2 antibody was performed. Proteins 
were also stained with CBBR, and the 60-kDa SVS2 (closed arrowhead) and the 
20-kDa Trx (open arrowhead) were observed. 
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Figure 7. Effect of thioredoxin (Trx) on sperm capacitation induced by MβCD. 
The rate of the acrosome reaction induced by progesterone (gray bars) or ionomycin 
(white bars) was evaluated. Conditions of sperm treatments are described in Figure 2. 
Data are shown as mean ± SD. Asterisks indicate significant differences compared with 
the spermatozoa incubated in HTF medium only (P < 0.01, Student’s t-test) (n = 3). 
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Figure 8. Effect of MβCD and SVS2 on sperm capacitation. 
The rate of the acrosome reaction induced by progesterone (gray bars) or ionomycin 
(white bars) was evaluated. Conditions of sperm treatments are described in Figure 2. 
Data are shown as mean ± SD. Asterisks indicate significant differences between the 
two groups (P < 0.01, Student’s t-test) (n = 3). 
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Figure 9. Effect of SVS2 on fertility induced by MβCD. 
The rate of the acrosome reaction induced by progesterone (gray bars) or ionomycin 
(white bars) was evaluated. Conditions of sperm treatments are described in Figure 2. 
Data are shown as mean ± SD. Asterisks indicate significant differences between the 
two groups (P < 0.01, Student’s t-test) (n = 3). 
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Figure 10. Influence of wash-treatment on the effect of SVS2. 
The rate of the acrosome reaction induced by progesterone (gray bars) or ionomycin 
(white bars) was evaluated. Conditions of sperm treatments are described in Figure 2. 
Data are shown as mean ± SD. Asterisks indicate significant differences compared with 
the spermatozoa incubated with MβCD (P < 0.01, Student’s t-test) (n = 3). 
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Figure 11. Evaluation of sperm viability. 
Spermatozoa were stained with propidium iodide and spermatozoa with no fluorescence 
were regarded as live. Data are shown as mean ± SD (n = 3).  
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Figure 12. Effect of ethanol, vehicle of cholesterol, on sperm capacitation. 
The rate of the acrosome reaction induced by progesterone (gray bars) or ionomycin 
(white bars) was evaluated. Data are shown as mean ± SD. Asterisks indicate significant 
differences compared with the spermatozoa incubated with MβCD (P < 0.01, Student’s 
t-test) (n = 3). 
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Figure 13. Effect of thioredoxin (Trx) on sterol levels in the sperm plasma 
membrane.  
The sterol content of each sperm sample is shown as a relative value: the normalized 
sterol content of the spermatozoa treated with HTF medium only was set to 100. Data 
are shown as mean ± SD of the fluorescence intensity of spermatozoa for each treatment. 
Asterisks indicate significant differences compared with the spermatozoa incubated in 
HTF medium only (P < 0.01, Student’s t-test) (n = 3). 
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Figure 14. Effect of MβCD and SVS2 on sterol level of the sperm plasma 
membrane. 
(A) A typical example of the distribution of fluorescence intensity of the spermatozoa 
from one batch. (B) Data are shown as mean ± SD of the fluorescence intensity of 
spermatozoa in each treatment. Conditions of sperm treatments are described in Figure 
2. Asterisks indicate significant differences compared with the spermatozoa incubated 
in HTF medium only (P < 0.01, Student’s t-test) (n = 3). 
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Figure 15. Enzymatic quantitation of cholesterol concentration in the sperm 
plasma membrane. 
The cholesterol content of each sperm sample is shown as a relative value: the 
normalized cholesterol content of the spermatozoa treated with HTF medium only was 
set to 100. Absolute quantity of the cholesterol in the control spermatozoa was 142.3 ± 
39.5 ng/106 sperm cells. Conditions of sperm treatments are described in Figure 2. Data 
are shown as mean ± SD, and asterisks indicate significant differences compared to 
spermatozoa incubated in HTF medium only (n = 4) (P < 0.01, Student’s t-test). 
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Figure 16. Visualization of cholesterol uptake into the sperm plasma membrane. 
(A) Fluorescence images of spermatozoa with BODIPY-cholesterol (green). Sperm 
heads were visualized by staining with Hoechst 33342 (blue) in the merged images 
(lower panels). Scale bar: 50 μm. (B) Rate of BODIPY-cholesterol incorporation into 
spermatozoa. Data are shown as mean ± SD (n = 3). Conditions of sperm treatments are 
described in Figure 2. Asterisks indicate significant differences compared with the B-Ch 
groups (P < 0.01, Student’s t-test). 
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Figure 17. Effect of SVS2 on distribution of lipid rafts on the sperm head.  
(A) Fluorescence images of GM1 signals observed in spermatozoa. Spermatozoa were 
fixed with PFA and GM1 was visualized using FITC-CTB. Pattern AA/PA: signal over 
anterior acrosome and postacrosome. Pattern PAPM: signal in postacrosome. Pattern 
APM/PAPM: weak signal in acrosome and remarkable signal in postacrosome. Pattern 
D: diffused signals through head. Scale bar: 5 μm. (B) Ratio of each GM1 localizing 
pattern in spermatozoa incubated under various conditions. Spermatozoa were obtained 
from one male mouse. Conditions of sperm treatments are described in Figure 2. 
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Table 1. Ratio of each GM1 pattern incubated under various conditions.  
Conditions of sperm treatments are described in Figure 2. Data are shown as mean ± SD 
(n = 3).  
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Figure 18. Amino acid sequence of mouse SVS2 
The seven putative cholesterol recognition/interaction domains are shown as gray 
boxes.  
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Dynamics of SVS2 and sperm capacitation  
in the female reproductive tract 
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ABSTRACT 
 Seminal vesicle secretion 2 (SVS2) suppresses sperm capacitation. In the 
uterus, SVS2 seems to inhibit sperm capacitation by interacting with ganglioside GM1 
on the spermatozoa. Since sperm capacitation needs to be induced in the oviduct, there 
must be a mechanism for removing GM1 and/or SVS2 from the spermatozoa. Indeed, 
spermatozoa entering the oviduct have neither GM1 nor SVS2. However, the dynamics 
of SVS2 in the female reproductive tract is yet unknown. In Chapter II, I analyzed the 
distribution of SVS2 and GM1 in the female reproductive tract. Furthermore, I 
investigated the capacitation-inducing factor in vivo. In mated female mice, SVS2 was 
detected in the uterus and at the uterotubal junction, while it was not found in the 
oviduct. GM1, which is known to bind to SVS2, was detected along the uterine 
epithelium of the estrus stage. Although sperm capacitation may be induced by sterol 
liberators such as albumin in the oviduct, the uterine concentration of albumin was also 
sufficient for sperm capacitation throughout the estrous cycle. It seems plausible that 
while sperm capacitation can be induced in the entire female reproductive tract, SVS2 
affects the uterine spermatozoa to keep in an incapacitated state. In summary, sperm 
capacitation might be regulated by SVS2-mediated inhibition and be induced by 
keeping SVS2 away from the spermatozoa.   
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INTRODUCTION 
 To acquire fertilizing ability, mammalian spermatozoa need to be capacitated in 
the female reproductive tract (Austin, 1951; Chang, 1951). Capacitated spermatozoa 
subsequently exhibit a change of flagellar motility, called hyperactivation, acrosome 
reaction, and penetration of the zona pellucida, before eventually fusing with the plasma 
membrane of the oocyte. Although sperm capacitation is indispensable for achieving 
mammalian fertilization, its regulatory mechanism is not clear.  
 Since albumin is required for inducing sperm capacitation in vitro (Brackett et 
al., 1972; Davis, 1976), it may also play an important role in capacitation in vivo. 
Albumin is present in the female reproductive tract (Miyamoto and Chang, 1973), and 
sperm capacitation is promoted by cholesterol transfer to albumin (Davis et al., 1979). 
On the other hand, there may be other factors concerned in sperm capacitation in vivo. 
Human follicular fluid contains high-density lipoprotein (Jaspard et al., 1996), while 
albumin mediates cholesterol transfer between cells and lipoproteins (Zhao and Marcel, 
1996). Apolipoproteins A−I and J in the female reproductive tract have been reported as 
inducers of cholesterol efflux from the sperm plasma membrane (Thérien et al., 1997; 
Argraves and Morales, 2004). According to these previous studies, it seems likely that 
albumin, supported by other factors, induces sterol efflux from the sperm plasma 
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membrane, resulting in the induction of sperm capacitation. However, the detailed 
mechanism of in vivo capacitation, namely the regulation of sterol dynamics in the 
sperm plasma membrane, is unknown.  
 The seminal plasma protein seminal vesicle secretion 2 (SVS2) prevents sperm 
capacitation and acts as a decapacitation factor (Kawano and Yoshida, 2007). SVS2 is 
directly ejaculated into the uterus with spermatozoa; it binds to ganglioside GM1 in 
their postacrosomal region, yet spermatozoa entering the oviduct have neither GM1 nor 
SVS2 (Kawano et al., 2008). Since capacitated spermatozoa cannot enter the oviduct 
(Shalgi et al., 1992), sperm capacitation seems to occur there. In conclusion, the effect 
of SVS2 on spermatozoa via GM1 may regulate in vivo capacitation.  
 Sperm capacitation in vivo may occur via an interaction between spermatozoa 
and the milieu of the female reproductive tract. Mouse spermatozoa are deposited in the 
uterus and migrate to the uterotubal junction (UTJ). The UTJ functions as a barrier to 
sperm entrance into the oviduct and as a site of sperm selection (Suarez, 2008). 
Spermatozoa seem to be selected according to two features: sperm motility and 
membrane properties. In hamsters, artificially inseminated spermatozoa that are already 
capacitated cannot pass through the UTJ owing to their hyperactivated motility (Shalgi 
et al., 1992). In mice, the deficiency of certain proteins yields infertility caused by 
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incapability of the UTJ passage (Druart, 2012). Although the function of the UTJ is 
unknown, it appears to be important for fertilization via regulating sperm capacitation. 
Thus, GM1 and/or SVS2 might be released from spermatozoa around the UTJ, resulting 
in sperm capacitation. However, the dynamics of SVS2 in the female reproductive tract 
and interactions between SVS2, spermatozoa, and the genital epithelium have not been 
elucidated. 
 In this chapter, I tried to examine the dynamics of SVS2 in the female 
reproductive tract. Particularly, the interaction between SVS2 and the genital epithelium 
was studied. Furthermore, to substantiate that sperm capacitation can occur in the uterus, 
I detected the potent capacitation-inducing factor albumin in the uterine fluid.  
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MATERIALS AND METHODS 
Immunohistochemistry of Female Reproductive Tracts 
 The anti-SVS2 polyclonal antibody was purified as described in Chapter I. 
 Nine−fifteen-week-old female mice (CD-1; Charles River Japan) were mated 
with 9−15-week-old male mice. At 1.5 h post-coitus, female reproductive tracts were 
obtained by dissection and fixed with 4% (w/v) PFA for 4−6 h. Samples were embedded 
in paraffin, and 10-μm-thick sections were cut according to standard protocols. 
 Immunohistochemistry was performed using the anti-SVS2 antibody (20 
μg/mL), followed by an Alexa 488-conjugated secondary antibody (goat anti-rabbit 
IgG; 1:20,000; Life Technologies, Carlsbad, CA, USA) with 0.2 μg/mL 
4',6-diamidino-2-phenylindole (DAPI) (Wako, Osaka, Japan). Anti-SVS2 antibody that 
was passed through a HiTrap NHS-activated HP column (GE Healthcare Japan, Tokyo, 
Japan) conjugated with recombinant SVS2 protein was used as the negative control. 
Stained sections were washed with PBS, analyzed using a fluorescent microscope 
(Leica DMRBE, Solms, Germany), and images were acquired using a CCD camera 
(MicroPublisher 5.0, QImaging, Surrey, BC, Canada). Exposure times were 5 s, 15 s, 
and 0.7s for anti-SVS2, control antibody, and DAPI staining, respectively.  
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Detection of GM1 in the Female Reproductive Tract 
 The estrous cycle stage of 9−15-week-old female mice was deduced by 
checking vaginal smears. Female reproductive tracts of each estrous cycle stage were 
obtained by dissection, fixed with 4% (w/v) PFA, embedded in paraffin, and 10-μm 
sections were cut as described above. Sections were stained with 0.1 mg/mL 
FITC-conjugated cholera toxin B subunit (FITC-CTB) in PBS for 12 h at 4°C. Stained 
sections were washed three times with PBS, visualized using a fluorescent microscope 
(Leica DMRBE) and images were acquired using a CCD camera (MicroPublisher 5.0, 
QImaging). Exposure time was 10 s for FITC-CTB staining. 
 
Quantification of Albumin in Uterine Fluid 
 The uteri of each estrous cycle stage of 9−15-week-old female mice (deduced 
as described above) were eviscerated, and surface fluid and blood were thoroughly 
removed. The uterus was hung in a tube, and uterine fluid was obtained by 
centrifugation at 1,200 × g for 3 min. Albumin levels in uterine fluid were quantified 
using an ELISA kit (Shibayagi Co., Gunma, Japan). 
 
Sperm Capacitation Assay 
 To evaluate the effect of SVS2 on sperm capacitation induced by high 
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concentrations of albumin, spermatozoa were isolated from the cauda epididymis of 
sexually mature 9−15-weeks-old male CD-1 mice, suspended in HTF medium, and 
incubated at 37°C in a 5% CO2 atmosphere. Bovine serum albumin (BSA, A-4503; 
Sigma-Aldrich) was used to induce sperm capacitation. Recombinant SVS2 protein was 
prepared as described in Chapter I and used at a concentration of 20μM, which is 
similar to the physiological concentration in the uterus (Kawano and Yoshida, 2007). 
Sperm capacitation was evaluated based on acrosomal responsiveness to progesterone 
and ionomycin, as described in Chapter I.   
 
Statistical Analysis 
 All experiments were repeated at least three times with different individuals. 
Data are expressed as mean ± SD. Statistical significance was calculated using the 
Student's t-test; P < 0.01 was considered statistically significant. 
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RESULTS 
Distribution of SVS2 in the Female Reproductive Tract 
 To evaluate the role of SVS2 in in vivo sperm capacitation, the dynamics of 
SVS2 quantities in the female reproductive tract after copulation was examined. In the 
uterine tube, SVS2 was found on the sperm clot, which may have been derived from 
free SVS2 in semen (Fig. 19). Furthermore, SVS2 was found on the surface of the 
uterine wall and on the wall of the uterotubal junction (UTJ), a passage from the uterus 
to the oviduct (Fig. 19). However, little SVS2 was detected in the oviductal isthmus (Fig. 
19). Although spermatozoa were seen in the isthmus, no SVS2 was detected on them.   
 
Distribution of GM1 in the Uterus 
 Since SVS2 specifically binds to ganglioside GM1, the distribution of GM1 in 
the female reproductive tract was examined. Although the amount is different, GM1 
localizes in many tissues (Iwamori and Nagai, 1981; Iwamori et al., 1984). While GM1 
was localized all over the uterine tube, intense GM1 staining of the uterine epithelium 
was only detected at the estrus stage and not at the proestrus, metestrus, or diestrus stage 
(Fig. 20).  
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Albumin in the Uterus 
 Since serum albumin is a potent cholesterol acceptor in vivo (Davis, 1981), the 
quantity of albumin in the uterine fluid was examined. The detected range of 6–108 
mg/mL throughout the estrous cycle (Table. 2) should be sufficient for inducing sperm 
capacitation.  
 
Effect of SVS2 on Sperm Capacitation Induced by High Concentrations of Albumin 
 As described above, the quantity of albumin detected in the uterus exceeded its 
concentration in the in vitro capacitation medium (3–5 mg/mL; Davis, 1979) 
considerably. Therefore, I examined the ability of SVS2 to suppress sperm capacitation 
in the presence of such high concentrations of bovine serum albumin (BSA). First, I 
confirmed that 100 mg/mL BSA do not influence sperm viability, using propidium 
iodide as described in Chapter I (Fig. 21). Second, 100 mg/mL BSA induced the same 
level of capacitation as 5 mg/mL BSA (Fig. 22A). Third, the physiological 
concentration of SVS2 in the uterus of 20 μM (Kawano and Yoshida, 2007) inhibited 
sperm capacitation even in the presence of 100 mg/mL BSA (Fig. 22B). These results 
indicate that SVS2 prevents sperm capacitation in the uterus, and keeps sperm 
incapacitated until they reach the oviduct.  
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DISCUSSION 
 In this chapter, I showed that the distribution of SVS2 in the female 
reproductive tract is restricted to the uterus and the UTJ. It was also shown that GM1 is 
located along the uterine epithelium in estrus and seems to retain SVS2 on the uterine 
wall. While there is plenty of albumin in the uterine fluid for inducing sperm 
capacitation, SVS2 could suppress sperm capacitation in vitro even in the presence of 
high concentrations of albumin as detected in the uterine fluid. These results indicate 
that SVS2 inhibits sperm capacitation in the uterus, while the effect of SVS2 seems to 
be excluded from the oviduct. 
 Since spermatozoa recovered from the oviduct possess neither SVS2 nor its 
receptor GM1 (Kawano and Yoshida, 2007; Kawano et al., 2008), the final event of in 
vivo capacitation may be removal of GM1 from the sperm plasma membrane. Indeed, 
GM1 and SVS2 appear to be liberated from spermatozoa at the UTJ. While the 
mechanism of this release is not known, the UTJ seems to function as a checkpoint for 
spermatozoa. When the sperm surface protein ADAM3 was disrupted as in Calmegin-/-, 
Adam1a-/-, Adam2-/-, and Ace-/- mice, spermatozoa could not migrate into the oviduct, 
resulting in infertility (Yamaguchi et al., 2009). As spermatozoa of SVS2-/- mice cannot 
enter the oviduct either (Kawano et al., 2014), these results indicate that the UTJ may 
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recognize physiological and molecular characteristics of spermatozoa and that only 
spermatozoa with specific protein(s) can interact with the epithelium and pass the UTJ.  
 In addition, the UTJ may be involved in the removal of molecules from 
spermatozoa. Spermadhesin AWN-1 localizes on spermatozoa and in seminal plasma 
and binds to the epithelium of the UTJ, while the oviductal fluid does not contain this 
protein (Calvete et al., 1997). This indicates that seminal plasma components are 
removed from spermatozoa in the UTJ. A previous study showed that GM1 binds to 
SVS2 via electrostatic interactions between the two molecules and that their affinity to 
each other changes depending on the pH (Kawano et al., 2008). As the pH of the 
oviductal fluid is higher than that of the uterine fluid in rhesus monkeys and cattle 
(Maas et al., 1977; Hugentobler et al., 2004), it seems possible that differences in 
environmental conditions such as pH can mediate the release of GM1 and/or SVS2 in 
the UTJ, ensuring that only naked spermatozoa pass through the UTJ and enter the 
oviduct. 
 Since high quantities of albumin were detected in the uterus (Table. 2), sterol 
liberators, which induce sperm capacitation, appear to be present throughout the entire 
female reproductive tract. Thus, in the female reproductive tract, spermatozoa may 
receive stimuli of opposite effects on sterols in their plasma membrane: an extracting 
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effect by liberators and a protecting effect by SVS2. In the uterus, SVS2 acts to inhibit 
sterol extraction and to intercalate sterols into the sperm plasma membrane, resulting in 
maintenance of sperm sterols. In the oviduct, the extracting effect surmounts the effect 
of SVS2, resulting in a decrease in sperm sterols. In other words, in vivo capacitation 
seems to be regulated not by a capacitation-inducing factor but by a decapacitation 
factor; SVS2 may be this factor regulating of sperm fertility in vivo.  
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Figure 19. Immunolocalization of SVS2 in the female reproductive tract.  
SVS2 in the female reproductive tract at 1.5 h post-coitus was stained with anti-SVS2 
antibody (green). Images of nuclei stained with DAPI (blue) superimposed on the 
immunostained images are shown in the lower panel. SVS2 entered the uterus and the 
UTJ region, but a very low amount entered the oviduct. Spermatozoa in the oviductal 
isthmus (arrow heads) had no SVS2. No antibody staining was detected in the controls. 
Scale bar: 50 μm. 
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Figure 20. Detection of GM1 on the uterine epithelium.  
Uteri of each estrous cycle stage were stained with FITC-CTB. Although GM1 localized 
all over the tissue in the uterine tube, intense GM1 staining of the uterine epithelium 
was only detected in estrus and not in proestrus, metestrus, or diestrus. Scale bar: 100 
µm.  
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Table 2. Albumin in the uterine fluid. 
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Figure 21. Evaluation of sperm viability. 
Spermatozoa were stained with propidium iodide, and spermatozoa with no 
fluorescence were regarded as live. Data are shown as mean ± SD (n = 3). 
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Figure 22. Effects of SVS2 on sperm capacitation induced by high concentrations 
of BSA.  
Acrosome reaction (AR) rate induced by progesterone (gray bars) or ionomycin (white 
bars). (A) Sperm capacitation induced by various concentrations of bovine serum 
albumin (BSA). (B) Effects of SVS2 on capacitation induced by various concentrations 
of BSA. Data are shown as mean ± SD. Asterisks indicate significant differences 
compared with sperm incubated without BSA nor SVS2 (P < 0.01, Student’s t-test) (n = 
3). 
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Chapter III 
 
Function and possible participation of SVS3 and SVS4  
in sperm capacitation 
 
3 章に関しては雑誌に投稿予定のため、非公開。 
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CONCLUSIONS and PERSPECTIVES 
 In the present thesis, I studied the role of SVSs proteins in sperm capacitation 
in mice. I have shown here that SVS2 maintains the sterol levels in the sperm plasma 
membrane to keep the spermatozoa in an incapacitated state. Since spermatozoa without 
SVS2 undergo ectopic sterol efflux in vivo, SVS2 must be a key factor that maintains 
sperm sterols and their fertilizing ability. I have also shown that SVS2 is prevented from 
entering the oviduct where sperm capacitation occurs. Thus, my study indicates that 
SVS2 is not only an inhibitor but also a regulator of sperm capacitation. Although SVS2 
seems to be the main player in sperm capacitation, SVS3 and SVS4 appear to be also 
partly involved in the process.  
 Interestingly, removal of the seminal vesicles causes complete infertility, while 
SVS2-/- mice show a decrease in litter size (Kawano et al., 2014). Furthermore, 
spermatozoa treated with SVSs have thicker coatings than spermatozoa treated with 
SVS2, which may contribute to protection against uterus-derived cytotoxic factors 
(Kawano et al., 2014). Previous reports have shown that SVS2−SVS6 are derived from 
one ancestor gene (Clauss et al., 2005) and evolved rapidly to adapt to various 
reproductive strategies (Ramm et al., 2009). Thus, while I showed roles of SVS3 and 
SVS4 on sperm capacitation in this study, SVSs other than SVS2 may have some roles 
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in sperm fertility and protection. Comprehensive functional analysis of SVSs will make 
us understand the significance of SVSs.   
 Several proteins suppressing sperm capacitation have been identified in the 
epididymis and the seminal vesicles (Yoshida et al., 2008). Some of those proteins also 
prevent cholesterol efflux from the spermatozoa. For example, glycodelin-S, a 
glycoprotein secreted from the seminal vesicles, inhibits the capacitation of the human 
spermatozoa by reducing the efflux of cholesterol and down-regulating the adenylyl 
cyclase/protein kinase A/tyrosine kinase signaling pathway (Chiu et al., 2005). 
Moreover, SERPINE2, a serine protease inhibitor, is expressed in the seminal vesicles 
(Vassalli et al., 1993) and it inhibits cholesterol efflux in the murine spermatozoa (Lu et 
al., 2011). Interestingly, SERPINE2-/- mice show loss of SVS2 and yield male infertility, 
suggesting that SVS2 is degraded by a protease (Murer et al., 2001). Since SVS2-/- mice 
showed the same phenotype as the SERPINE2-/- mice, SVS2 can be said to play an 
important role in sperm fertility. Although it is not known whether all potential 
decapacitation factors function in vivo, the induction of sperm capacitation may require 
the decontrol of multiple decapacitation factors. These multiple systems that guarantee 
reliable sperm capacitation are my areas of interest.  
  Since sperm capacitation is a complex phenomenon in which many signaling 
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pathways are intricately intertwined, the molecular mechanisms still remain elusive. My 
study showed that in vivo sperm capacitation is regulated by the dynamic changes of 
sterol levels in the sperm plasma membrane, which is mediated by SVS2 and 
capacitation-inducing factor(s). Hitherto, factors inducing sperm capacitation have been 
intensely investigated. However, considering that capacitation-inducing factor(s) seem 
to exist in the entire female reproductive tract (Chapter II), in vivo capacitation seems to 
be triggered not by the induction with inducing factor(s), but by suppressing the 
function of decapacitation factors. Therefore, SVS2 is the key factor regulating the 
sperm's fertilizing ability as it is able to control the inhibition and the induction of sperm 
capacitation in vivo.  
 Considering the current scientific knowledge, I propose the following model of 
in vivo sperm capacitation (Fig. 34): after mating, mouse spermatozoa that have high 
sterol levels enter the uterus. The ejaculated semen contains SVS2, and SVS2 attaches 
to the postacrosomal region of the spermatozoa via GM1 (Kawano and Yoshida, 2007; 
Kawano et al., 2008). While there are some capacitation-inducing factors such as 
albumin in the uterus, the sterol levels in the sperm plasma membrane are maintained by 
SVS2. When sterol is released from the sperm plasma membrane either spontaneously 
or through the function of capacitation-inducing factors, SVS2 retrieves free cholesterol, 
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resulting in maintaining spermatozoa in an incapacitated state. When spermatozoa enter 
the oviduct, both GM1 and SVS2 are detached from the spermatozoa, leading to the 
capacitation of oviductal spermatozoa by the capacitation-inducing factor. In this 
process, there are two indispensable steps for the accomplishment of murine 
fertilization: (1) the inhibition of capacitation in inappropriate sites, which is mediated 
by decapacitation factors, (2) the induction of capacitation by removing decapacitation 
factors and GM1, a possible wedge of lipid rafts. There must be mechanisms assuring 
the precise occurrence of both events and their elucidation will give us more insight into 
the mammalian fertilization process. 
 In the present thesis, I focused on sterol liberators such as albumin and 
methyl-β-cyclodextrin which seem to be needed for sperm capacitation. However, 
factors other than sterol liberators are also required for capacitation: for example, 
bicarbonate is essential for sperm capacitation (Boatman and Robins, 1991). 
Bicarbonate induces tyrosine phosphorylation of sperm proteins to trigger 
hyperactivation accompanied by sperm capacitation (Visconti et al., 1999b), and the 
oviductal fluid has a high concentration of bicarbonate (Okamura et al., 1985; Foley and 
Williams, 1991). Thus, the effect of bicarbonate on the regulation of sperm capacitation 
should be elucidated in the future. 
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 Since I studied the function of secretory proteins from the seminal vesicles in 
mice, I am interested in whether these findings can be applied to other species. Some 
reports have shown a relationship between the seminal vesicles and fertility in humans. 
An insufficient volume of ejaculate, caused by an abnormality of the seminal vesicles, 
may be related to infertility (Lotti et al., 2012). While ejaculated spermatozoa of normal 
healthy men have little semenogelin (SEMG), ejaculated spermatozoa of 
asthenozoospermic patients have more SEMG, suggesting that it is related to infertility 
(Terai et al., 2010). Thus, the seminal vesicles in humans may have a similar relation to 
fertility as in mice. Interestingly, a number of carnivores such as cats and dogs have no 
seminal vesicles. In dogs, sperm capacitation is induced by glycosaminoglycans that 
exist in the uterine and oviductal fluid (Kawakami et al., 2000), suggesting that sperm 
capacitation in dogs may be regulated by factors other than SVSs proteins. Therefore, 
elaborate studies should be done to understand the regulatory mechanisms of 
capacitation in different species.  
 My study showed that proteins secreted from the seminal vesicles regulate 
sperm capacitation actively and coordinately, which can account for the significance of 
seminal vesicles and their secretions in mammals. I hope this study contributes to the 
understanding of the beginning of our life−mammalian fertilization.   
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Figure 34. Working hypothesis for in vivo sperm capacitation regulated by SVS2. 
In the uterus, SVS2 attaches to spermatozoa via GM1 and suppresses efflux of sterols 
such as cholesterol (Ch) to inhibit sperm capacitation. When sterols are occasionally 
released from spermatozoa, SVS2 retrieves them to the sperm plasma membrane. In the 
oviduct, SVS2 and GM1 are detached from spermatozoa. This induces sterol efflux, 
resulting in sperm capacitation.  
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